Cambrex secures acquisition in Ireland, increasing their European footprint

Tyler Patchen

News Reporter

Ireland continues to be a hot spot for pharma manufacturers, with Merck KGaA announcing last week a $470 million-plus investment into expanding and building …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Cambrex secures acquisition in Ireland, increasing their European footprint

Tyler Patchen

News Reporter

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Pfizer CEO says opportunities with Trump ‘clearly outweigh’ the risks for pharma

CBER's deputy director departs as staff shakeup continues

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

FDA approves first drug to treat ultra-rare lipid storage disease

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Cam­brex se­cures ac­qui­si­tion in Ire­land, in­creas­ing their Eu­ro­pean foot­print

News Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Cambrex secures acquisition in Ireland, increasing their European footprint